Cairo — Egypt’s stock market ended Monday, 4 May 2026 on a mixed note, with losses in large-cap stocks pulling the benchmark lower even as smaller shares advanced, according to data from the Egyptian Exchange (EGX).
The EGX30 fell 0.65% to 51,973.5 points, easing back below the 52,000-point level. The EGX33 Shariah index declined 0.35%, while the EGX35-LV dropped 0.56%, indicating pressure on large-cap names.
In contrast, the EGX70 index of small and medium-sized companies rose 0.59% to 14,387.83 points, while the EGX100 edged up 0.15% to 19,973.12 points, reflecting relative resilience in the broader market. Total market capitalization stood at approximately EGP 3.682tn, EGX data showed.
Investor flows remained divergent. Egyptian investors were net buyers by EGP 25.77bn, broadly offsetting net foreign selling of EGP 24.13bn and Arab outflows of EGP 1.64bn, underscoring the role of domestic liquidity in supporting prices.
Gains were concentrated in selected names, with Amer Group Holding rising 11.48%, Nozha International Hospital up 9.52%, and El-Nile Company for Pharmaceuticals and Chemical Industries advancing 9.21%. On the downside, Misr Fertilizers Production Company (MOPCO) fell 10.10%, while Alexandria New Medical Center and Cairo Educational Services also declined.
Regionally, sentiment remains cautious. Recent reporting by Reuters indicates Middle East markets continue to respond to developments in US-Iran negotiations, with oil prices and shipping risks in the Strait of Hormuz influencing investor positioning.
The session highlights continued divergence between large-cap weakness and broader market resilience, with domestic buying offsetting foreign outflows. Near-term direction will depend on whether foreign participation stabilises and on the trajectory of regional risk conditions.
